tirzepatide and missed period Does Mess With Your Period? Hormone Effects Hey mamas, first time posting

The FDA approved Wegovy for chronic weight management in June 2021, making it the first GLP-1 medication specifically indicated for obesity treatment in non-diabetic patients

Semaglutide is a GLP-1 receptor agonist, a peptide-based medication

We adjust formulations, add peptide boosters, or transition you to maintenance frequency based on results

The shorter BUDs reflect that

The Bottom Line AOD 9604 is an intriguing peptide therapy that may help support fat metabolism and healthy aging, particularly for adults over 50 dealing with stubborn weight gain and metabolic changes

Medications will only be prescribed by a licensed clinician if deemed medically appropriate after a thorough consultation